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MicroRNAs: emerging players in apical 
periodontitis
Apical periodontitis is an inflammatory disorder of periradicular tissues 
developed from endodontic infections. Understanding its pathophysiology 
and the underlying molecular mechanisms is key to the advancement of 
endodontics. MicroRNAs (miRNAs), a group of evolutionarily conserved small 
non-coding RNAs, may be phenotypically and functionally associated with the 
pathogenesis of apical periodontitis. Several studies have focused on the role 
of miRNAs in the pulp and periradicular biology, and they have demonstrated 
their essential functions, such as initiating odontogenic differentiation and 
promoting pro- or anti-inflammatory responses in pulpitis. Up to date, over 
2,000 miRNAs have been discovered in humans; however, only few have 
been reported to associate with apical periodontitis. Therefore, identifying 
miRNAs involved in diseased apical tissues and conducting functional studies 
are important in expanding our current knowledge of pulp and periradicular 
biology and exploring novel therapeutic avenues. In this review, we revisit 
current models of apical periodontitis and miRNA biogenesis, analyze existing 
evidence of the involvement of miRNAs in diseased apical tissues, and 
discuss their diverse functions and potential values. Based on their sheer 
abundance, prolonged stability in biofluid, and relative ease of sampling, 
miRNAs may be a useful tool to be developed as diagnostic biomarkers for 
apical periodontitis. Furthermore, it can be used as therapeutic targets in 
conjunction with conventional endodontic therapies.
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Introduction
Microbes in the oral environment are the primary 
cause of infection in the root canal system as well as 
dental pulp and periapical tissues.1 Apical periodontitis 
– as one of the consequences of endodontic infections 
– is a chronic inflammatory disorder of periradicular 
tissues.2 It involves the dynamic interaction between 
host immune response and microbial factors at 
the interface between infected radicular pulp and 
periodontal ligament, and it is usually manifested by 
localized inflammation, hard tissue resorption, and 
destruction of other periapical tissues.3 
Root canal therapy aims to reduce microbial 
infection and restore an aseptic environment to 
minimize apical lesions and promote bone healing. 
However, persistent apical periodontitis occurs when 
endodontic treatment has not adequately eliminated 
the infection or when reinfection occurs because of 
inadequate coronal seal or microleakage.2,3 Recent 
research advances have provided numerous molecular 
targets and novel endodontic techniques that may ease 
the development of biomarkers in early diagnosis and 
the translation of novel therapeutic tools to promote 
apical tissue regeneration. Among these targets, 
microRNAs – as a class of novel molecules – have 
recently emerged as essential regulators of these 
processes, and their therapeutic values have just 
begun to be appreciated.
Pathophysiology of apical periodontitis
The exact etiology of apical periodontitis has 
not been well elucidated. Evidence has shown that 
bacteria – especially Gram-negative bacteria – and 
their toxins, enzymes, and metabolic byproducts play 
a significant role in inducing host immune response.4 
Lipopolysaccharides (LPS) or endotoxin, is a major 
component of the cell wall of Gram-negative bacteria.4 
It is often secreted by growing organisms or released 
during the disintegration of bacteria.4 It is one of the 
most important virulence factors and potent stimuli 
of immune cells such as macrophages, with the lipid 
A moiety responsible for the toxic effects of LPS.5 
LPS evokes host immune response by activating 
pattern recognition receptors (PRRs) such as Toll-like 
receptors (TLRs) and CD14 signaling. These signaling 
events subsequently induce the production of pro-
inflammatory cytokines, such as tumor necrosis 
factor-alpha (TNF-α), interleukin-1 (IL-1), IL-8, IL-12, 
IL-17, and anti-inflammatory cytokines such as IL-4 
and IL-10.5-7
Periapical inflammatory responses can cause 
tissue damage and the development of granulomas 
or radicular cysts by a complex cellular and molecular 
cascade.8 For instance, matrix metalloproteinases 
(MMPs) – a group of more than 25 secreted and 
membrane-bound enzymes – are regulated by pro-
inflammatory cytokines and growth factors, and play 
one of the key roles in tissue destruction and normal 
tissue modeling.9 In particular, MMP-1, MMP-2, MMP-
3, MMP-8, MMP-9, and MMP-13 have been found in 
periapical lesions. Collagen, as well as extracellular 
matrix (ECM) degradation, have been associated with 
increased levels of MMPs.9
In addition to pathophysiological changes in 
connective tissues, periapical inflammation also 
leads to alveolar bone resorption.3 Bone turnover 
depends on the equilibrium between osteoblast-
mediated bone formation and osteoclast-mediated 
bone destruction, and the osteoclast activities are 
regulated by the receptor activator of NF-kappa B 
(RANK), its ligand RANKL, and the decoy receptor 
of RANKL, osteoprotegerin (OPG).10 The binding of 
RANKL to RANK drives the maturation of osteoclasts. 
Studies have shown that pro-inflammatory cytokines 
can induce the expression of RANKL, which leads to 
increased osteoclast activities and subsequent bone 
resorption.10 
It is noteworthy that complex interactions between 
inflammatory cells and cytokines influence the balance 
between pro- and anti-inflammatory processes that, 
in turn, affect the equilibrium between destruction 
and regeneration of apical tissues.11 For example, 
anti-inflammatory cytokines, such as IL-4 and IL-
10, can restrain inflammatory cytokine production 
and inhibit the function of MMPs and RANKL by 
stimulating the production of tissue inhibitors of matrix 
metalloproteinases (TIMPs) and OPG, respectively.12
MicroRNA
MicroRNAs (miRNAs) are a class of evolutionally 
conserved non-coding RNAs of ~23 nucleotides that 
regulate gene expression predominantly at the post-
transcriptional level.13 Since its initial discovery of 
lin-4 in Caenorhabditis elegans in 1993, hundreds of 
miRNAs have been identified and extensively studied 
in a wide spectrum of species.14,15
Mammalian miRNAs are encoded in both intergenic 
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and intragenic regions of the genome.16 In general, 
miRNA genes are first transcribed into long primary 
transcripts, called pri-miRNAs. Pri-miRNAs are 
processed by the nuclear RNase III Drosha/DGCR8 to 
generate ∼70 base pair-long pre-miRNAs that are then 
exported by Exportin-5 to the cytoplasm in a Ran-GTP 
dependent manner.17 In the cytoplasm, pre-miRNAs are 
further processed by the RNase III Dicer to yield ~21-
25 nucleotide-long mature miRNAs.17 They bind to the 
3’ untranslated region (UTR) of the target messenger 
RNAs (mRNAs) via partial sequence complementarity 
and subsequently lead to translational inhibition and 
mRNA decay of the target genes.13
MiRNAs play key roles in development, as evident 
from early mouse model studies that knockout 
of miRNA processing proteins causes embryonic 
lethality.18 Over the past two decades, miRNAs have 
also been associated with many dental pulp disorders 
and diseases, with many studies shedding light on their 
potential diagnostic and prognostic values.19
MicroRNAs in apical periodontitis
Recent miRNA profiling studies have shown that 
miRNAs play an important role in the pathogenesis of 
endodontic apical periodontitis.20-22 Gao and Zheng20 
(2013), investigated the differential expression of 
miRNAs in rat apical periodontitis via microarray 
analysis, and target genes of these miRNAs and their 
biological functions were predicted. Interestingly, 
particular enrichment in the MAPK signaling pathways 
was reported. Chan, et al.21 (2013) identified 381 
miRNAs from diseased periapical tissues collected from 
patients undergoing endodontic surgery compared 
with those of healthy pulps using microarray analyses, 
and they found that 24 miRNAs were downregulated 
in diseased periapical tissues compared with controls. 
They further confirmed seven downregulated miRNAs 
using quantitative real-time polymerase chain reaction 
(PCR) and predicted their targets that include key 
mediators in the immune and inflammatory response, 
such as IL-6, MMP-9, and TGF-β.21
Although a large number of miRNAs have been 
identified in apical periodontitis, only few were 
further studied and characterized. For example, 
Yue, et al.22 (2016) found that miR-155 played a key 
role in inflammation and the progression of apical 
periodontitis by inhibiting SEMA3A. In another study, 
Yue, et al.23 (2017) revealed that miR-335-5p acted 
as a positive mediator in human periodontal ligament 
fibroblasts (HPDLFs) inflammation and identified two 
targets, uPAR and RANKL. They found that uPAR was 
repressed by miR-335-5p at the basal level, but when 
HPDLFs were subjected to LPS stimulation, it could 
be relieved from miR-335-5p-mediated repression, 
a process called derepression; whereas miR-335-5p 
promoted RANKL in HPDLFs regardless of whether or 
not it was under inflammatory conditions.23
Lina, et al.24 (2019) discovered miR-146a and Hey2 
(hairy and enhancer-of-split related with YRPW motif 
2) expressions were significantly higher in 20 patients 
with chronic apical periodontitis. Moreover, they 
elucidated miR-146a acted as an anti-inflammatory 
mediator and negatively regulated the expression of 
IL-6, IL-1β, and TNF-α.24 They also confirmed Hey2 was 
a target gene of miR-146a and negatively regulated 
miR-146a, IL-6, IL-1β, and TNF-α expressions, 
suggesting that miR-146a and Hey2 form a mutual 
negative feedback regulatory loop in chronic apical 
periodontitis.24
Wang, et al.25 (2019) reported that miR-181b-5p 
was downregulated in TNF-α-stimulated cementoblasts, 
and overexpressing miR-181b-5p negatively regulated 
IL-6 and pro-inflammatory chemokine, indicating 
miR-181b-5p moderates pro-inflammatory chemokine 
production by targeting IL-6 in cementoblasts. 
Interestingly, they found miR-181b-5p promoted 
cementoblast apoptosis, which may enhance the 
resolution of inflammation.25
Recently, the association between polymorphisms 
in genes encoding estrogen receptors 1 and 2 (ESR1 
and ESR2), vitamin D receptor (VDR), and in miRNA-17 
with apical periodontitis was reported in the literature. 
This study included 162 patients who had received 
endodontic therapy. Among them, 89 patients were 
considered “healed,” whereas 73 patients were 
diagnosed with persistent apical periodontitis at the 
follow-up visit. They found that genetic polymorphisms 
in ESR1 (rs2234693 and rs9340799), ESR2 (rs1256049 
and rs4986938), VDR (rs739837 and rs2228570), 
and miRNA-17 (rs4284505) were not associated with 
persistent apical periodontitis.26
Not only did these findings confirm the diverse 
and complex miRNA regulatory network in apical 
periodontitis, but they also indicated that a few 
potential areas of study may be conducted in the future 
to further advance our understanding of miRNAs. 
First, differential expression patterns of miRNAs 
may be cell type-specific. As mentioned before, 
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apical periodontitis involves several cell types, such 
as polymorphonuclear leukocytes, macrophages, 
lymphocytes, plasma cells, fibroblasts, epithelial cells, 
and vascular cells.27 As a result, miRNA profiling may 
reflect a pool of different patterns. It is highly possible 
that some miRNAs are only expressed or differentially 
expressed in certain cell types. Therefore, cell type-
specific miRNA profiling will have great significance. 
An excellent example comes from Naqvi, et al.28 
(2016) that performed miRNA profiling in primary 
human macrophages challenged with LPS, and they 
found that these miRNA profiles were responsive to 
LPS dose and incubation time.28 Recent advancement 
in the single-cell RNA sequencing technology is also 
likely to generate significant insights into the cellular 
heterogeneity of apical periodontitis and in-depth 
molecular signatures.
Second, the development of sequencing techniques 
– the next-generation miRNA sequencing (miRNA-
seq) – will significantly change our understanding 
of miRNAs. Compared with miRNA profiling studies 
using microarray analysis, miRNA-seq eliminates the 
requirement of sequence-specific probes and enables 
an unbiased study of miRNA expression landscape 
and discovery of novel miRNAs.29 Recently, our group 
performed a large-scale next-generation miRNA-seq 
analysis of human diseased and healthy apical tissues 
to identify differentially expressed miRNAs in apical 
periodontitis.30 As a result, a total of 852 miRNAs 
were identified, out of which 12 were significantly 
upregulated (1.54-8.44 fold), and 94 were significantly 
downregulated (0.14-0.67 fold). Moreover, 515 novel 
miRNAs expressed an appreciable level.30 
Third, once the differentially expressed and/
or novel miRNAs are identified, functional studies 
will become the key in determining how these 
miRNAs contribute to the pathophysiology of apical 
periodontitis. Immunohistochemistry and fluorescence 
in situ hybridization may give us clues on the 
specific cell types in which those miRNAs reside. In 
addition, miRNA mimics and inhibitors can be readily 
synthesized and introduced into in vitro and in vivo 
experimental systems; changes of predicted miRNA 
target genes can be examined at the mRNA levels and 
protein levels via molecular biology and biochemistry 
techniques such as real-time PCR, western blotting, 
and enzyme-linked immunosorbent assay (ELISA); 
and biological pathways involving those target genes 
can then be established. Furthermore, using in vitro 
luciferase assays or similar techniques, direct target 
genes of differentially expressed miRNAs can be 
easily screened out. For example, our recent miRNA-
seq analysis revealed that miR-10a-5p was highly 
expressed in apical periodontitis, and overexpression 
of miR-10a-5p in vitro resulted in the downregulation 
of TNF-α and upregulation of IL-10, indicating that 
this most significantly upregulated miRNA in apical 
periodontitis may function in suppressing inflammation 
and promoting healing.30 Therefore, functional 
characterization of miRNAs plays a pivotal role in 
understanding the pathophysiology and will ease the 
development of biomarkers and therapeutic targets 
in apical periodontitis.
MicroRNAs as biomarkers for apical periodontitis
MiRNAs have been used as biomarkers in many 
diseases and medical conditions to aid diagnosis and 
prognosis. The same concept can be applied to miRNAs 
in apical periodontitis as chairside diagnostic tools 
based on their sheer abundance, prolonged stability, 
and relative ease of sampling.31 
For example, when pulp exposure is encountered 
during caries excavation, pulpal fluid or blood can be 
easily sampled using instruments such as syringes or 
microcannulas, and miRNA levels can be assessed. 
If specific pro-inflammatory miRNAs are detected at 
increased levels, this may indicate a substantial extent 
of inflammation. Therefore, direct pulp capping or 
other vital pulp therapies may have a poor prognosis in 
this situation, and non-surgical root canal therapy may 
be the recommended treatment option. Conversely, 
the detection of high levels of anti-inflammatory 
miRNAs may indicate a good prognosis of performing 
vital pulp therapy (Figure 1).
This concept can also be used for non-surgical root 
canal treatment. Similarly, pulpal and periapical fluid 
can be obtained during the procedure. If high levels 
of certain pro-inflammatory miRNAs are detected in 
the apical area, it may shift the prognosis of healing 
to questionable. In this case, a surgical approach 
following non-surgical root canal treatment can be 
discussed in advance and planned if necessary (Figure 
1). This will greatly enhance the informed decision-
making process, and patient-centered treatment 
options can also be better tailored and rendered.
In addition, if miRNA profiling can be further 
stratified based on symptomatology (symptomatic 
vs. asymptomatic) or severity of the symptoms, this 
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would aid our prediction of pre-/post-op pain levels 
and better facilitate pain management for patients.
MicroRNAs as therapeutic targets for apical 
periodontitis 
Similar to the idea of biomarkers, miRNAs can 
also be designed as therapeutic targets.31 As hinted 
at above, inhibitors of pro-inflammatory miRNAs or 
mimics of anti-inflammatory miRNAs can be used 
in conjunction with traditional endodontic therapies. 
This type of treatment aims to prevent or inhibit the 
inflammatory process in apical periodontitis (Figure 
1). It was recently demonstrated that miR-10a-5p 
may suppress inflammation in apical periodontitis.30 
If this can be further shown with in vivo studies, then 
miR-10a-5p has the potential to be developed as a 
therapeutic agent and be used as an adjunct therapy 
along with the conventional endodontic treatment.
Currently, several miRNA-based therapeutics are 
undergoing clinical trials targeting diseases such as 
hepatitis C, scleroderma, mesothelioma, non-small cell 
lung cancer, cutaneous T cell lymphoma, and mycosis 
fungoides.32 These all shed light on the potential use 
of miRNAs in treating apical periodontitis. One of the 
major challenges is the degradation of exogenous 
miRNA products (miRNA mimics and inhibitors) by 
endogenous nucleases. Chemical modifications, such 
as the addition of a 2’-O-methyl group or locked nucleic 
acids (LNAs), may significantly increase their stability. 
Another challenge is the targeted delivery of miRNA 
products to the disease sites. Lipid nanoparticles is one 
of the commonly used systems for the delivery of small 
molecules and have been developed for delivering 
miRNAs to target sites.32 Compared to cancers and 
some other diseases, apical periodontitis typically 
presents localized diseased tissues, which makes it 
easier for clinicians to target it. Thus, miRNA products 
may be distributed via intracanal delivery using a 
microcannula or by local infiltration using a syringe 
during non-surgical root canal treatment (Figure 1), or 
by direct application during apical surgery. Despite all 
the technical hurdles, the identification and functional 
study of miRNAs is significant.
What if the damage already exists, such as 
bone resorption and diseased tissue formation? 
Can miRNAs help repair or regenerate destructed 
tissues? Studies on the functions of miRNAs in the 
odontogenic differentiation of stem cells may give 
Figure 1- Potential clinical translation for the use of miRNAs in the treatment of pulpal and periapical diseases.
As many novel miRNAs are being unveiled, they have the potential to be translated into chairside diagnostic biomarkers and therapeutic 
agents. For example, before any endodontic treatment, pulpal/periapical fluid and blood can be easily sampled using instruments such as 
syringes or microcannulas, from which miRNA levels can be assessed. Based on the differential expression patterns of specific miRNAs 
that are associated with characteristics and/or prognostic factors of apical periodontitis, informed decision-making can be achieved, 
and patient-centered treatment options can be tailored and rendered. On the other hand, if specific miRNAs are known to play a role in 
pro- and anti-inflammatory process, their inhibitors/mimics can be applied to inflamed pulp tissues in conjunction with conventional vital 
pulp therapies such as direct pulp capping or delivered to the root canals and periapical regions using microcannulas during root canal 
therapies to promote better healing outcomes.
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us a clue.19,33 Taking human dental pulp stem cells 
(DPSCs) as an example, several miRNAs are associated 
with their odontogenic potentials. For instance, miR-
21 and STAT3 (signal transducer and activator of 
transcription 3) formed a positive reciprocal feedback 
loop in the signaling pathway that enhanced the 
process of odontogenic differentiation of DPSCs.34 
MiR-223-3p was significantly upregulated in inflamed 
dental pulp, and the overexpression of miR-223-3p 
in DPSCs significantly increased the protein levels 
of dentine sialophosphoprotein (DSPP) and dentin 
matrix protein 1 (DMP-1), thus promoting odontoblast 
differentiation.35 In contrast, some miRNAs show anti-
odontogenic differentiation properties. Downregulation 
of miR-143-5p promoted the differentiation of DPSCs 
into odontoblasts by enhancing Runx2 expression via 
the OPG/RANKL signaling pathway and by activating 
the p38 MAPK signaling pathway.36,37 Similarly, the 
downregulation of miRNA-488 also enhanced the 
odontoblast differentiation of DPSCs via activation of 
the p38 MAPK signaling pathway.38 Another miRNA, 
miR-140-5p was significantly decreased during 
LPS-mediated differentiation of DPSCs in vitro, 
and overexpression of miR-140-5p enhanced DPSC 
proliferation and inhibited DPSC differentiation.39
As many known miRNAs being characterized and 
novel miRNAs being unveiled in apical periodontitis, 
it is promising that more therapeutic targets 
within this family of small non-coding RNAs will be 
identified, and apical periodontitis will be tackled 
from multiple biological pathways such as suppression 
of inflammation, promotion of wound healing, and 
differentiation of stem cells. A MiRNA cocktail therapy 
may not be an unrealistic assumption.
Conclusion
Understanding the biology of pulpal and periradicular 
tissues is key to the advancement of endodontics. The 
central dogma of DNA-RNA-Protein axis has been well 
studied over the past half-century. However, miRNAs, 
as a class of novel non-protein coding RNAs, have 
just begun to be appreciated. Compared to other 
cellular processes, fewer studies have focused on the 
role of miRNAs in pulp and periradicular biology but 
have already demonstrated their essential functions. 
Therefore, identifying miRNAs in apical periodontitis 
and conducting functional studies are important in 
unveiling the big picture and expanding the current 
knowledge of pulp biology. Furthermore, based on 
the sheer abundance, prolonged stability, and relative 
ease of sampling, miRNAs may be a useful tool to 
be developed as diagnostic biomarkers for apical 
periodontitis and can be used as biological materials 
in conjunction with conventional endodontic therapies.
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